company background image
1733 logo

Apex Biotechnology TWSE:1733 Stock Report

Last Price

NT$34.30

Market Cap

NT$3.4b

7D

0.9%

1Y

32.9%

Updated

28 Mar, 2024

Data

Company Financials

Apex Biotechnology Corp.

TWSE:1733 Stock Report

Market Cap: NT$3.4b

1733 Stock Overview

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide.

1733 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends2/6

Apex Biotechnology Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Apex Biotechnology
Historical stock prices
Current Share PriceNT$34.30
52 Week HighNT$44.45
52 Week LowNT$25.60
Beta0.41
1 Month Change1.48%
3 Month Change-14.89%
1 Year Change32.95%
3 Year Change42.62%
5 Year Change1.03%
Change since IPO102.59%

Recent News & Updates

Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Mar 21
Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Recent updates

Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Mar 21
Apex Biotechnology's (TWSE:1733) Conservative Accounting Might Explain Soft Earnings

Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business

Apr 17
Apex Biotechnology's (TPE:1733) Returns On Capital Not Reflecting Well On The Business

Is Apex Biotechnology (TPE:1733) Using Too Much Debt?

Mar 30
Is Apex Biotechnology (TPE:1733) Using Too Much Debt?

Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?

Mar 10
Is Apex Biotechnology Corp. (TPE:1733) A Good Fit For Your Dividend Portfolio?

Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?

Feb 17
Is Apex Biotechnology Corp.'s (TPE:1733) Stock On A Downtrend As A Result Of Its Poor Financials?

A Look At Apex Biotechnology's (TPE:1733) Share Price Returns

Jan 27
A Look At Apex Biotechnology's (TPE:1733) Share Price Returns

Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture

Jan 06
Returns On Capital At Apex Biotechnology (TPE:1733) Paint An Interesting Picture

These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely

Dec 16
These 4 Measures Indicate That Apex Biotechnology (TPE:1733) Is Using Debt Safely

Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?

Nov 22
Is Apex Biotechnology Corp.'s (TPE:1733) 4.5% Dividend Worth Your Time?

Shareholder Returns

1733TW Medical EquipmentTW Market
7D0.9%-0.5%1.9%
1Y32.9%6.2%26.7%

Return vs Industry: 1733 exceeded the TW Medical Equipment industry which returned 6.2% over the past year.

Return vs Market: 1733 exceeded the TW Market which returned 26.7% over the past year.

Price Volatility

Is 1733's price volatile compared to industry and market?
1733 volatility
1733 Average Weekly Movement5.2%
Medical Equipment Industry Average Movement3.8%
Market Average Movement4.2%
10% most volatile stocks in TW Market8.0%
10% least volatile stocks in TW Market1.9%

Stable Share Price: 1733 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1733's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997n/aThomas Y. Shenhttps://www.apexbio.com

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing, and hemoglobin screening systems. It also provides pesticide residue check systems; and care management and tele-health services.

Apex Biotechnology Corp. Fundamentals Summary

How do Apex Biotechnology's earnings and revenue compare to its market cap?
1733 fundamental statistics
Market capNT$3.43b
Earnings (TTM)NT$115.78m
Revenue (TTM)NT$1.68b

29.6x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1733 income statement (TTM)
RevenueNT$1.68b
Cost of RevenueNT$1.15b
Gross ProfitNT$531.12m
Other ExpensesNT$415.33m
EarningsNT$115.78m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.16
Gross Margin31.68%
Net Profit Margin6.91%
Debt/Equity Ratio1.7%

How did 1733 perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

95%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.